ALPHACENTRIC ADVISORS LLC Arcutis Biotherapeutics, Inc. Transaction History

ALPHACENTRIC ADVISORS LLC portfolio value:

$0
portfolio value

ALPHACENTRIC ADVISORS LLC quarter portfolio value change:

-6.69%
quarter

Arcutis Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -52.5K shares -1.08M $19.11 0
Q4 2021 share Increase +47.89% 17K shares 241K $20.48 52.5K
Q3 2021 share Increase +162.96% 22K shares 480K $23.89 35.5K
Q2 2021 share Increase +12.50% 1.5K shares 21K $27.29 13.5K
Q1 2021 share Increase 0.00% 12K shares 347K $28.93 12K